Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Giraud

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Neuroreport|March 27, 1999
A selective imaging of tinnitusA L Giraud, S Chéry-Croze, G Fischer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 2, 2019
Neonatal and self-healing linear immunoglobulin A dermatosisL Giraud, A Welfringer-Morin, O Boccara, et al.
Nanoscale|August 22, 2024
Surface-anchored carbon nanomaterials for antimicrobial surfacesL Giraud, O Marsan, E Dague, et al.
British Journal of Clinical Pharmacology|August 6, 2021
Body weight gain in clozapine-treated patients: Is norclozapine the culprit?Naomi T Jessurun, Hieronymus J Derijks, Rob J van Marum, et al.
The Journal of Small Animal Practice|December 9, 2024
Clinical presentation, diagnostic findings and short-term outcome in French bulldogs with presumptive spinal only meningoencephalomyelitis of unknown origin: 15 cases (2016-2023)R Boudou, T Troupel, A S Bedu, et al.
Clinical Pharmacology and Therapeutics|June 1, 2025
Exploring the Association Between Intra-Patient Variability in Trough Concentration of Pazopanib and Clinical Outcomes in Renal Cell Carcinoma and Soft Tissue Sarcoma PatientsAmy Rieborn, Eline L Giraud, Teun van Gelder, et al.
Cancers|June 10, 2023
Measuring Tumour Imatinib Concentrations in Gastrointestinal Stromal Tumours: Relevant or Redundant?Eline L Giraud, Loek A W de Jong, Erik van den Hombergh, et al.
British Journal of Clinical Pharmacology|September 30, 2023
Results of the first international quality control programme for oral targeted oncolyticsEline L Giraud, Lindsey M H Te Brake, Erik C A van den Hombergh, et al.
Expert Opinion on Drug Safety|September 29, 2020
Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patientsEline L Giraud, Naomi T Jessurun, Florence P A M van Hunsel, et al.
The Lancet. Oncology|September 2, 2022
The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overviewEline L Giraud, Kaylee R M Ferrier, Nienke A G Lankheet, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Neuroreport|March 27, 1999
A selective imaging of tinnitusA L Giraud, S Chéry-Croze, G Fischer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 2, 2019
Neonatal and self-healing linear immunoglobulin A dermatosisL Giraud, A Welfringer-Morin, O Boccara, et al.
Nanoscale|August 22, 2024
Surface-anchored carbon nanomaterials for antimicrobial surfacesL Giraud, O Marsan, E Dague, et al.
British Journal of Clinical Pharmacology|August 6, 2021
Body weight gain in clozapine-treated patients: Is norclozapine the culprit?Naomi T Jessurun, Hieronymus J Derijks, Rob J van Marum, et al.
The Journal of Small Animal Practice|December 9, 2024
Clinical presentation, diagnostic findings and short-term outcome in French bulldogs with presumptive spinal only meningoencephalomyelitis of unknown origin: 15 cases (2016-2023)R Boudou, T Troupel, A S Bedu, et al.
Clinical Pharmacology and Therapeutics|June 1, 2025
Exploring the Association Between Intra-Patient Variability in Trough Concentration of Pazopanib and Clinical Outcomes in Renal Cell Carcinoma and Soft Tissue Sarcoma PatientsAmy Rieborn, Eline L Giraud, Teun van Gelder, et al.
Cancers|June 10, 2023
Measuring Tumour Imatinib Concentrations in Gastrointestinal Stromal Tumours: Relevant or Redundant?Eline L Giraud, Loek A W de Jong, Erik van den Hombergh, et al.
British Journal of Clinical Pharmacology|September 30, 2023
Results of the first international quality control programme for oral targeted oncolyticsEline L Giraud, Lindsey M H Te Brake, Erik C A van den Hombergh, et al.
Expert Opinion on Drug Safety|September 29, 2020
Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patientsEline L Giraud, Naomi T Jessurun, Florence P A M van Hunsel, et al.
The Lancet. Oncology|September 2, 2022
The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overviewEline L Giraud, Kaylee R M Ferrier, Nienke A G Lankheet, et al.
Pageof 6